Advertisement

Ads Placeholder
Loading...

AusCann Group Holdings Ltd

AC8.AXASX
Healthcare
Drug Manufacturers - Specialty & Generic
$0.04
$0.00(0.00%)
Australian Market opens in 61h 25m

AusCann Group Holdings Ltd Fundamental Analysis

AusCann Group Holdings Ltd (AC8.AX) shows weak financial fundamentals with a PE ratio of -1.63, profit margin of -9.77%, and ROE of -61.32%. The company generates $0.0B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

Cash Position41.41%
PEG Ratio-0.02
Current Ratio49.47

Areas of Concern

ROE-61.32%
Operating Margin-1.25%
We analyze AC8.AX's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -955.2/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-955.2/100

We analyze AC8.AX's fundamental strength across five key dimensions:

Efficiency Score

Weak

AC8.AX struggles to generate sufficient returns from assets.

ROA > 10%
-1.48%

Valuation Score

Excellent

AC8.AX trades at attractive valuation levels.

PE < 25
-1.63
PEG Ratio < 2
-0.02

Growth Score

Weak

AC8.AX faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Excellent

AC8.AX maintains a strong and stable balance sheet.

Debt/Equity < 1
0.00
Current Ratio > 1
49.47

Profitability Score

Weak

AC8.AX struggles to sustain strong margins.

ROE > 15%
-6131.82%
Net Margin ≥ 15%
-9.77%
Positive Free Cash Flow
No

Key Financial Metrics

Is AC8.AX Expensive or Cheap?

P/E Ratio

AC8.AX trades at -1.63 times earnings. This suggests potential undervaluation.

-1.63

PEG Ratio

When adjusting for growth, AC8.AX's PEG of -0.02 indicates potential undervaluation.

-0.02

Price to Book

The market values AusCann Group Holdings Ltd at 1.03 times its book value. This may indicate undervaluation.

1.03

EV/EBITDA

Enterprise value stands at -9.19 times EBITDA. This is generally considered low.

-9.19

How Well Does AC8.AX Make Money?

Net Profit Margin

For every $100 in sales, AusCann Group Holdings Ltd keeps $-9.77 as profit after all expenses.

-9.77%

Operating Margin

Core operations generate -1.25 in profit for every $100 in revenue, before interest and taxes.

-1.25%

ROE

Management delivers $-61.32 in profit for every $100 of shareholder equity.

-61.32%

ROA

AusCann Group Holdings Ltd generates $-1.48 in profit for every $100 in assets, demonstrating efficient asset deployment.

-1.48%

Following the Money - Real Cash Generation

Operating Cash Flow

AusCann Group Holdings Ltd generates limited operating cash flow of $-3.33M, signaling weaker underlying cash strength.

$-3.33M

Free Cash Flow

AusCann Group Holdings Ltd generates weak or negative free cash flow of $-3.66M, restricting financial flexibility.

$-3.66M

FCF Per Share

Each share generates $-0.01 in free cash annually.

$-0.01

FCF Yield

AC8.AX converts -20.76% of its market value into free cash.

-20.76%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-1.63

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.02

vs 25 benchmark

P/B Ratio

Price to book value ratio

1.03

vs 25 benchmark

P/S Ratio

Price to sales ratio

15.92

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.00

vs 25 benchmark

Current Ratio

Current assets to current liabilities

49.47

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.61

vs 25 benchmark

ROA

Return on assets percentage

-1.48

vs 25 benchmark

ROCE

Return on capital employed

-0.19

vs 25 benchmark

How AC8.AX Stacks Against Its Sector Peers

MetricAC8.AX ValueSector AveragePerformance
P/E Ratio-1.6328.54 Better (Cheaper)
ROE-61.32%738.00% Weak
Net Margin-977.06%-43982.00% (disorted) Weak
Debt/Equity0.000.34 Strong (Low Leverage)
Current Ratio49.472806.01 Strong Liquidity
ROA-147.56%-14624.00% (disorted) Weak

AC8.AX outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews AusCann Group Holdings Ltd's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ